Gemphire Therapeutics Email Format

Pharmaceutical ManufacturingMichigan, United States0-1 Employees

Gemphire Therapeutics is a clinical-stage biopharmaceutical company based in Livonia, Michigan, focused on therapies for dyslipidemia, a condition that increases the risk of serious cardiovascular disease. Its lead candidate, gemcabene (CI 1027), is an oral therapy intended for patients who cannot reach target LDL-C or triglyceride levels with existing treatments, especially statins. Gemcabene is designed to promote clearance of VLDLs and reduce hepatic production of fatty acids and cholesterol, and the company is exploring its use for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

Gemphire operates within the pharmaceutical industry, pursuing a development path that includes late-stage trials for a range of dyslipidemia indications—from orphan conditions to more prevalent disorders. The company maintains a very small staff.

Get verified Gemphire Therapeutics emails free

Company overview Employee directory